Multiple Sclerosis (MS) Drugs

| Avonex | Betaseron | Betaferon | Copaxone | Rebif |

 

Copaxone ® (glatiramer acetate)

MS Drugs - Copaxone ® Efficacy (Effectiveness of Copaxone ®)

How effective is Copaxone ®?

% of patients relapse free at 2 years
Placebo Copaxone ®
27% 34%

 

Number of patients progression free completing 2 years of Copaxone ®
% of patients progression free at 2 years Placebo Copaxone ®
75% 78%

 

Mean relapse rate
Mean relapse rate over 2 years Placebo Copaxone ®
1.68 1.19

 

Average time to first relapse
Average number of days till first relapse Placebo Copaxone ®
198 days 287 days

 

† Progression is defined as an increase in at least 1 point in the DSS (Kurtzke Expanded Disability Scale) for at least 3 consecutive months

Ref: Copaxone® prescribing information

 

 

 

Multiple Sclerosis

2002 – A patient with Multiple Sclerosis can expect to live to average population life-expectancy minus seven years (mean life expectancy - 7 years).

What is Multiple Sclerosis?

Multiple sclerosis is currently thought to be an autoimmune disease. An autoimmune disease is one where the body's immune system is thought to attack its own cells and therefore cause damage.... Read More